Search
Ronidazole
go.drugbank.com/drugs/DB20601ExperimentalThe usage of the INN stem '-nidazole' in the name indicates that Ronidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Pirazolac
go.drugbank.com/drugs/DB20690ExperimentalThe usage of the INN stem '-ac' in the name indicates that Pirazolac is a anti-inflammatory agent, ibufenac derivative. Pirazolac has a monoisotopic molecular weight of 330.06 Da.
Halazone
go.drugbank.com/drugs/DB20704ExperimentalThe usage of the INN stem '-azone' in the name indicates that Halazone is a anti-inflammatory analgesic, phenylbutazone derivative. Halazone has a monoisotopic molecular weight of 268.93 Da.
Pirinidazole
go.drugbank.com/drugs/DB21413ExperimentalThe usage of the INN stem '-nidazole' in the name indicates that Pirinidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalThe usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative. Tifurac has a monoisotopic molecular weight of 326.06 Da.
Canocapavir
go.drugbank.com/drugs/DB21570ExperimentalThe usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor. Canocapavir has a monoisotopic molecular weight of 561.08 Da.
Emzeltrectinib
go.drugbank.com/drugs/DB21605ExperimentalThe usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da.
Zavondemstat
go.drugbank.com/drugs/DB21608ExperimentalThe usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor. Zavondemstat has a monoisotopic molecular weight of 431.22 Da.
SARS-CoV-2 Sclamp
go.drugbank.com/drugs/DB15849InvestigationalTetraQ, Australian National University (ANU), the University of Melbourne, and the Peter Doherty Institute for Infection and Immunity are also involved in the clinical component. … Preclinical trials showed the vaccine candidate produced high levels of neutralizing antibodies, and induced a strong T-cell response.
Timapiprant
go.drugbank.com/drugs/DB11900InvestigationalOC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.